[The Role of non-Statin Therapy for Lowering the Concentration of low-Density Lipoprotein Cholesterol and Reducing the Risk of Developing Atherosclerotic Cardiovascular Complications].
The article provides comments on 2016 American College of Cardiology Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk. The reasons for publishing this document are discussed, in particular appearance of results of conducted during last 3 years clinical trials of new highly effective non-statin medications. The article contains descriptions of indications, contraindications to the use of these agents as of their possible side effects. The preferred order of their administration in combination with statins in different categories of patients is also presented.